UnitedHealth Group (UNH, Financials) announced the resignation of CEO Andrew Witty on Tuesday and suspended its annual forecast, sending the stock down more than 15% to a four-year low. Warning! GuruFocus has detected 3 Warning Sign with UNH. The company attributed the guidance withdrawal to a spike in healthcare demand from patients with complex conditions, a trend that has increased costs across its insurance business. The stock drop follows an earlier 20% slide on April 17 after a forecast cut. Witty's resignation came just weeks after the company reported its first earnings miss since 2008. Former CEO Stephen Hemsley, 72, will return to lead the company. Analysts view his appointment as a stopgap measure amid ongoing challenges. UnitedHealth has faced multiple headwinds over the past year, including a cyberattack affecting 190 million people, a Medicare billing investigation, and the December murder of insurance unit CEO Brian Thompson. Peers including Humana (HUM, Financials), CVS Health (CVS, Financials), and Elevance Health (ELV, Financials) were also impacted by sector-wide jitters but have since rebounded. UnitedHealth expects to return to growth in 2026 and plans to price Medicare Advantage plans more aggressively to reflect rising care utilization. Some analysts speculated Witty may have been pushed out, citing investor dissatisfaction with recent performance and guidance cuts. See insider trades for UNH. Explore Peter Lynch chart. This article first appeared on GuruFocus. View Comments
UnitedHealth (UNH) Sinks 15% as CEO Exits, Forecast Withdrawn
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...